A) The ease of obtaining stem cells from adults. B) The uncontroversial ethical implications. C) The lack of potential applications. D) The use of embryonic stem cells.
A) Ethical guidelines and regulations. B) Speed of research progress above all else. C) Ignoring public opinions and concerns. D) Funding from private corporations only.
A) To address regulatory disparities and ensure ethical standards. B) To hinder progress in the field. C) To avoid sharing scientific breakthroughs. D) To eliminate competition among research institutions.
A) Providing expertise on ethical implications and considerations. B) Opposing all forms of medical research involving stem cells. C) Serving as decision-makers for all stem cell research projects. D) Advocating for unrestricted research with no ethical oversight.
A) Promoting unregulated stem cell experimentation. B) Excluding patient advocates from the research process. C) Developing international policy guidance on stem cell research. D) Creating financial barriers to stem cell research.
A) Totipotent cells can develop into any type of cell, including embryonic tissues, while pluripotent cells can develop into almost any type of cell. B) There is no difference between the two types of stem cells. C) Pluripotent cells are more versatile than totipotent cells. D) Pluripotent cells can only divide a limited number of times.
A) Repair, replace, and regenerate damaged cells or tissues. B) Create artificial intelligence using stem cells. C) Replace traditional medicine for all illnesses. D) Speed up the aging process in patients.
A) To only focus on economic factors. B) To address diverse views on ethics, religious beliefs, and values that impact policy decisions. C) To ignore public opinions and concerns. D) To prioritize scientific progress over societal implications. |